 |
Welcome to Agilent in Pharmaceutical Analysis!
In this issue, learn the sure way to pinpoint empirical formulas of unknowns. Discover how to simplify sample filtration for HPLC. Find out how to save money and time with laboratory instrumentation and software that help your lab work smarter. For the latest word on pharmaceutical solutions, explore the links on this page.
Keep Pharmaceutical Analysis coming!
Agilent in Pharmaceutical Analysis is filled with valuable information and handy tips to make your life easier and your lab more productive. Best of all, it's FREE! Don't wait. Subscribe today!
|
|
 |
|
Dependable Accurate Mass Measurements Help
to Identify Unknowns
Statistics demonstrate the consistent mass accuracy of the LC/MSD TOF, which is so important for limiting the number of possible empirical formulas for unknown analytes.
Read article.
|
|
|
Get the Latest LC and GC Technology for Less
Upgrade now from your Agilent 1050 liquid chromatograph or your Agilent 5890A gas chromatograph to new instruments and enjoy 15 percent savings on everything you need.
Read article.
|
|
|
New Options Increase the Versatility of Your LC/MSD
Read about solutions that boost productivity and flexibility for your new or existing LC/MSD quadrupole mass spectrometer.
Read article.
|
|
|
Accelerate with the Latest MSD Security ChemStation
The newest software revision provides integration with Laboratory Information Management Systems, along with many other productivity enhancements.
Read article.
|
|
|
 |
|
Ask the Experts: What is the Best Overall Membrane Filter for HPLC Sample Filtration?
Now you can use a single, nearly universal membrane filter—with better performance than the filter you may be using today.
Read article.
|
|
|
 |
 |
Win a USB flash drive!
Help make this newsletter one that truly meets your needs. Complete our online survey and earn a chance to win. Survey available in language.
Affordable Enterprise Content Management
Cerity ECM runtime bundles provide integrated turnkey solutions at affordable prices. Find out more.
|
|
|
|
|
|
|
|
|
|
|